Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 4Neuroblastoma 3Glioma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Neoplasms, Germ Cell and Embryonal 1Meningioma 1Hemangiopericytoma 1Hemangioma, Cavernous, Central Nervous System 1Hemangioma, Cavernous 1Hemangioblastoma 1Gliosarcoma 1Glioblastoma 1Ganglioneuroblastoma 1Ependymoma 1Choroid Plexus Neoplasms 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 16Hydroxyurea 7Everolimus 7Bevacizumab 7lutetium Lu 177 dotatate 6gallium Ga 68 dotatate 6Radiosurgery 6Proton Therapy 6Specimen Handling 5pembrolizumab 4Surveys and Questionnaires 4Surgical Procedures, Operative 4Radiotherapy 4Imatinib Mesylate 4Cyclophosphamide 42-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4aldesleukin 3abemaciclib 3Tranexamic Acid 3Temozolomide 3Sunitinib 3Sodium Chloride 3Radiotherapy, Intensity-Modulated 3Observation 3Nivolumab 3Ga(III)-DOTATOC 390Y-octreotide, DOTA-Tyr(3)- 3vistusertib 2trametinib 2ribociclib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningioma × Watchful Waiting × CNS × Clear all
NCT03180268 2026-05-07

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

NRG Oncology

Phase 3 Recruiting
163 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡